Future Market Insights (FMI) released its latest report on biophotonics market. The market is expected to register a CAGR of over 11.3% between 2021 and 2031. The study takes into account the impact of COVID-19 on Biophotonics Market.
The global biophotonics market is driven by factors such as Increasing ageing population, the government support in technology innovations, enhanced range of biophotonics applications, and a need for improvement in healthcare.
Region-wise, North America was the highest contributor to the global biophotonics market, followed by Europe, the Middle East and Africa (EMEA) and Asia Pacific. However, the North America is expected exhibit a CAGR of over 10.9% during the forecast period
According to end-user type, the global biophotonics market is segmented as Medical diagnostics, Medical therapeutics, Test components and Non- Medical. The medical diagnostics is expected to dominate the global biophotonics market and register a CAGR of over 10.7%during the forecast period.
Non-medical applications are projected to demonstrate an impressive growth rate of over 15.5% CAGR between 2021 and 2031. Growth in global biophotonics market is largely attributed to growth in end use sectors, which largely include diagnostic centers, medical institutes, healthcare service providers, research institutes and laboratories, and medical & scientific instrument manufacturers.
By application type, the Global Biophotonics market is segmented as See through imaging, Spectro molecular, Inside imaging, Biosensors, Surface imaging, Microscopy, Light therapy, and other analytic sensing. Among all the aforementioned segments, the biosensors is projected to witness over 17.2% CAGR during the forecast period. The microscopy and light therapy applications are expected to exhibit a CAGR of 15.1 % each respectively between 2021 and 2031.
The growth is attributed to implementation of the biosensors in other analytic sensing segment due to its specific biological analyte sensing capability such as pregnancy test, food toxicity, and cholesterol tests. Key players in the global biophotonics market are Becton, Dickinson & Co., Affymetrix Inc., Carl Zeiss, Olympus America, Andor Technology and Hamamatsu Photonics.